Skip to main content
Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
0.8000
+0.0200 (2.56%)
May 28, 2025, 2:12 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Diagnostic Clinical Services
40.21M
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Clinical Services Growth
26.31%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
40.21M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
26.31%
Log In
Log In
Log In
Log In
Upgrade